Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?

446 Followers

Candel Therapeutics (CADL) Ownership Overview

9.52% Insiders

16.20% Mutual Funds

1.75% Other Institutional Investors

6.92% ETFs

65.61% Public Companies and

Individual Investors

The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 24.88% of the company’s stock is owned by Institutional Investors, 9.52% is owned by Insiders, and 65.61% is owned by Public Companies and Individual Investors.

The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 17.95% of the company’s stock is owned by Institutional Investors, 9.52% is owned by Insiders, and 6.92% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Feb 26, 2026	Paul B Manning	xxxxxxxxxxxxx	$2999996

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	5,911,951	Institution	8.07%	38,250,323
	5,748,279	Insider	7.85%	37,191,365
	2,719,055	Institution	3.71%	17,592,286
	2,675,697	Institution	3.65%	17,311,760
	2,185,004	Institution	2.98%	14,136,976
	1,724,779	Institution	2.35%	11,159,320
	546,863	Insider	0.75%	3,538,204
	464,141	Institution	0.63%	3,002,992
	384,194	Institution	0.52%	2,485,735
Felix Baker	355,112	Institution	0.48%	2,297,575

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
5,911,951	Institution	8.07%	38,250,323
2,719,055	Institution	3.71%	17,592,286
1,724,779	Institution	2.35%	11,159,320
464,141	Institution	0.63%	3,002,992
384,194	Institution	0.52%	2,485,735
259,032	Institution	0.35%	1,675,937
127,407	Institution	0.17%	824,323
90,473	Institution	0.12%	585,360
50,000	Institution	0.07%	323,500
25,307	Institution	0.03%	163,736

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,968,034	Institution	2.69%	9,643,367
iShares Russell 2000 ETF	1,071,915	Institution	1.46%	6,935,290
Vanguard Extended Market ETF	439,414	Institution	0.60%	2,153,129
iShares Biotechnology ETF	396,282	Institution	0.54%	2,563,945
iShares Russell 2000 Growth ETF	347,365	Institution	0.47%	2,247,452
Vanguard Russell 2000 ETF	224,863	Institution	0.31%	1,101,829
iShares Core S&P Total U.S. Stock Market ETF	119,732	Institution	0.16%	774,666
iShares Micro-Cap ETF	117,191	Institution	0.16%	758,226
ALPS Medical Breakthroughs ETF	71,288	Institution	0.10%	461,233
iShares NASDAQ US Biotechnology UCITS ETF	51,399	Institution	0.07%	317,646

FAQ

Who Owns Candel Therapeutics (CADL)?

According to the latest TipRanks data, approximately 1.75% of the company's stock is held by institutional investors, 9.52% is held by insiders, and 65.61% is held by retail investors.

What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.75% of Candel Therapeutics (CADL) stock is held by institutional investors.

What percentage of Candel Therapeutics (CADL) stock is held by retail investors?

According to the latest TipRanks data, approximately 65.61% of Candel Therapeutics (CADL) stock is held by retail investors.

Who owns the most shares of Candel Therapeutics (CADL)?

Fidelity Select Portfolios owns the most shares of Candel Therapeutics (CADL).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.